Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization
Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Genovis SmartEnzymes™ and Waters LC-MS Instrumentation. · Collaboration intended to bring speed and simplicity to bio-characterization workflows · Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories · Waters and Genovis share mutual goal to advance the science behind the analysis of glycoproteins and protein therapeuticsGenovis and Waters (NYSE:WAT) are formally collaborating to develop and market